Correlation Between 89bio and Beam Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both 89bio and Beam Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 89bio and Beam Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 89bio Inc and Beam Therapeutics, you can compare the effects of market volatilities on 89bio and Beam Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 89bio with a short position of Beam Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of 89bio and Beam Therapeutics.

Diversification Opportunities for 89bio and Beam Therapeutics

0.5
  Correlation Coefficient

Very weak diversification

The 3 months correlation between 89bio and Beam is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding 89bio Inc and Beam Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Beam Therapeutics and 89bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 89bio Inc are associated (or correlated) with Beam Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Beam Therapeutics has no effect on the direction of 89bio i.e., 89bio and Beam Therapeutics go up and down completely randomly.

Pair Corralation between 89bio and Beam Therapeutics

Given the investment horizon of 90 days 89bio is expected to generate 6.75 times less return on investment than Beam Therapeutics. In addition to that, 89bio is 1.05 times more volatile than Beam Therapeutics. It trades about 0.0 of its total potential returns per unit of risk. Beam Therapeutics is currently generating about 0.02 per unit of volatility. If you would invest  3,009  in Beam Therapeutics on November 28, 2024 and sell it today you would lose (141.00) from holding Beam Therapeutics or give up 4.69% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

89bio Inc  vs.  Beam Therapeutics

 Performance 
       Timeline  
89bio Inc 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in 89bio Inc are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat conflicting basic indicators, 89bio sustained solid returns over the last few months and may actually be approaching a breakup point.
Beam Therapeutics 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Beam Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain basic indicators, Beam Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

89bio and Beam Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with 89bio and Beam Therapeutics

The main advantage of trading using opposite 89bio and Beam Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 89bio position performs unexpectedly, Beam Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Beam Therapeutics will offset losses from the drop in Beam Therapeutics' long position.
The idea behind 89bio Inc and Beam Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes